LH(Labcorp Holdings Inc.) 的财务报表:医疗保健,诊断与研究。数据来自 SEC 公开申报与市场行情,不构成投资建议。
| 科目 | FY 截至 2021-12-31 | FY 截至 2022-12-31 | FY 截至 2023-12-31 | FY 截至 2024-12-31 | FY 截至 2025-12-31 |
|---|---|---|---|---|---|
| 营业收入 | $13.14B | $11.86B | $12.16B | $13.01B | $13.95B |
| 毛利润 | $4.99B | $3.71B | $3.36B | $3.62B | $4.01B |
| 营业利润 | $3.05B | $1.44B | $725.60M | $1.09B | $1.38B |
| 净利润 | $2.38B | $1.28B | $418.00M | $746.00M | $876.50M |
| 经营现金流 | $3.11B | $1.96B | $1.33B | $1.59B | $1.64B |
| 自由现金流 | $2.69B | $1.53B | $874.10M | $1.10B | $1.21B |
| 摊薄每股收益 | $24.39 | $13.97 | $4.77 | $8.84 | $10.46 |